Updated August 31 at 6:31pm
Biotechnology
34 results total, viewing 1 - 10
Amgen Inc. won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a new class of treatments to come to market. more
Medtronic PLC will spend as much as $458 million to buy Twelve Inc., becoming the latest medical-device giant to buy an experimental product to replace the heart’s mitral valve without open-heart surgery. more
(Updated, 4 p.m., Aug. 21) Some of the region’s most notable companies have been named in Providence Business News’ fourth Fastest-Growing & Innovative Companies awards program. more
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
Tivorsan Pharmaceuticals Inc. has named James E. Connolly CEO. The biotechnology company, which focuses on treating Duchenne Muscular Dystrophy and other neuromuscular disorders, also said that Connolly will serve as a member of its board. more
The first two patients in IlluminOss Medical Inc.’s U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures have been successfully treated at the Marshall University Joan C. Edwards School of Medicine. more
The Defense Threat Reduction Agency is investing $5.2 million for the development of a new type of vaccine against Q fever, and a local company is involved in the effort. more
ProThera Biologics has appointed Denice M. Spero as president and chief business officer. more
Medrobotics Corp. was named a “rising star” in the Smaller Business Association of New England Inc.’s 2015 New England Innovation Awards. more
Amy Orlick Berman has been appointed IlluminOss Medical’s vice president of clinical affairs. more
1 | 2 | 3 | 4 Next »